Lance Berman

Lance Berman is Chief Medical Officer of Pulmocide and brings over 25 years of experience in clinical development, medical affairs and corporate leadership from his time in big pharma and in the small biotech start-up space. Most recently Lance was Chief Medical Officer and Senior Vice President at Relypsa in the San Francisco Bay area where he was responsible for building and leading the Company’s clinical development, medical affairs and drug safety functions; as well as playing a key role in the preparation and execution of the Company’s IPO. In addition to having worked across multiple therapeutic areas in clinical development, he has also worked closely with commercial teams to secure product reimbursement and to plan and execute product launches. Lance also serves as a Venture Partner at Ysios Capital and sits on the Board of Oxthera.

Lance received his Bachelor of Medicine and Bachelor of Surgery (MB.ChB) degree from the University of Cape Town, South Africa and holds a Master’s in Science in Pharmaceutical Medicine.